Anti-hyperglycemic and hypolipidemic effects of Cistanche tubulosa in type 2 diabetic db/db mice

被引:115
|
作者
Xiong, Wen-Ting [1 ]
Gu, Li [1 ]
Wang, Chao [1 ]
Sun, Hong-Xia [1 ]
Liu, Xin [1 ]
机构
[1] Sun Yat Sen Univ, Sch Life Sci, State Educ Minist, Food & Hlth Engn Res Ctr, Guangzhou 510275, Guangdong, Peoples R China
关键词
Cistanche tubulosa; Type; 2; diabetes; Anti-hyperglycemic effect; Hypolipidemic effect; FASTING PLASMA-GLUCOSE; ANTIOXIDANT CAPACITY; PHENOLIC-COMPOUNDS; MANAGEMENT; HEALTH; OBESE; CONSTITUENTS; VERBASCOSIDE; PATHOGENESIS; HOMEOSTASIS;
D O I
10.1016/j.jep.2013.09.027
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Ethnopharmacological relevance: The dried succulent stem of Cistanche tubulosa (Schenk) R. Wight is one component of traditional Chinese medicine prescriptions for diabetes. However, there have been no modern scientific reports to confirm this traditional claim for the Cistanche species until now. Thus, we investigated the effects of Cistanche tubulosa on glucose homeostasis and serum lipids in male BKS. Cg-Dock7(m) +/+ Lepr(db)/J (db/db) mice, a model of type 2 diabetes. Materials and methods: The verbascoside and echinacoside contents of Cistanche tubulosa powder were evaluated using HPLC. The total phenolic content, polysaccharide content and antioxidant activity of Cistanche tubulosa powder were also evaluated. Then, different doses of Cistanche tubulosa (equivalent to 120.9, 72.6 or 24.2 mg verbascoside/kg) were administered orally once daily for 45 days to male db/db mice. Age matched db/+ mice were used as normal controls. Body weight, fasting blood glucose, postprandial blood glucose and insulin tolerance test were measured during the experiment. At the time of sacrifice, blood was collected for measurement of insulin level, the homeostatic model assessment of insulin resistance (HOMA-IR), and total cholesterol, triglyceride, HDL-c, LDL-c and VLDL-c levels; liver and muscle were harvested for measurement of glycogen levels. Results: Cistanche tubulosa significantly suppressed the elevated fasting blood glucose and postprandial blood glucose levels, improved insulin resistance and dyslipidemia, and suppressed body weight loss in db/db mice. However, Cistanche tubulosa did not significantly affect serum insulin levels or hepatic and muscle glycogen levels. Conclusion: This study provides scientific evidence for the traditional use of Cistanche tubulosa to treat diabetes, suggesting that Cistanche tubulosa has the potential for development into a functional food ingredient or drug to prevent hyperglycemia and treat hyperlipidemia. (C) 2013 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:935 / 945
页数:11
相关论文
共 50 条
  • [21] Anti-diabetic activities of catalpol in db/db mice
    Bao, Qinwen
    Shen, Xiaozhu
    Qian, Li
    Gong, Chen
    Nie, Maoxiao
    Dong, Yan
    KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY, 2016, 20 (02): : 153 - 160
  • [22] Anti-diabetic effects of cytopiloyne in db/db mice and its likely mechanism
    Hsu, Yi-Jou
    Chang, Cicero Lee-Tian
    Lee, Yi-Mei
    Chang, Shu-Lin
    Pan, Chien-Yuen
    Yang, Ning-Sun
    Yang, Wen-Chin
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 79 : S127 - S127
  • [23] Red clover extract exerts antidiabetic and hypolipidemic effects in db/db mice
    Qiu, Longxin
    Chen, Tong
    Zhong, Fojin
    Hong, Yamin
    Chen, Limei
    Ye, Hong
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2012, 4 (04) : 699 - 704
  • [24] Renoprotective Effects of Canagliflozin in Db/db Diabetic Mice
    Thanekar, Unmesha
    Gill, Rupinder K.
    Dhakal, Sanjeev
    Hosawi, Anhar
    Elased, Khalid M.
    HYPERTENSION, 2019, 74
  • [25] The role of interstitial macrophages in nephropathy of type 2 diabetic db/db mice
    Ninichuk, Volha
    Khandoga, Alexander G.
    Segerer, Stephan
    Loetscher, Pius
    Schlapbach, Achim
    Revesz, Laszlo
    Feifel, Roland
    Khandoga, Andrej
    Krombach, Fritz
    Nelson, Peter J.
    Schloendorff, Detlef
    Anders, Hans-Joachim
    AMERICAN JOURNAL OF PATHOLOGY, 2007, 170 (04): : 1267 - 1276
  • [26] LM 4156, a novel, balanced activator of PPAR α and γ with anti-hyperglycemic and HDL elevator properties in db/db and human apoA1 mice
    Contard, F
    Berard, I
    Yvon, S
    Decerprit, J
    Guerrier, D
    DIABETES, 2003, 52 : A115 - A115
  • [27] Transcriptional Profile of Kidney from Type 2 Diabetic db/db Mice
    Zhang, Haojun
    Zhao, Tingting
    Li, Zhiguo
    Yan, Meihua
    Zhao, Hailing
    Zhu, Bin
    Li, Ping
    JOURNAL OF DIABETES RESEARCH, 2017, 2017
  • [28] Metformin accelerates wound healing in type 2 diabetic db/db mice
    Han, Xue
    Tao, Yulong
    Deng, Yaping
    Yu, Jiawen
    Sun, Yuannan
    Jiang, Guojun
    MOLECULAR MEDICINE REPORTS, 2017, 16 (06) : 8691 - 8698
  • [29] Regulation of foam cell formation in Type 2 diabetic db/db mice
    Mauldin, JP
    Gebre, AK
    Bolick, DT
    Srinivasan, S
    Parks, JS
    Hedrick, CC
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (05) : E79 - E79
  • [30] Beneficial effects of phlorizin on diabetic nephropathy in diabetic db/db mice
    Pei, Fei
    Li, Bao-ying
    Zhang, Zhen
    Yu, Fei
    Li, Xiao-li
    Lu, Wei-da
    Cai, Qian
    Gao, Hai-qing
    Shen, Lin
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2014, 28 (05) : 596 - 603